DBV Technologies announces filing of 2022 Annual Report on Form 10-K and 2022 Universal Registration Document
Montrouge, France, March 2, 2023
DBV Technologies announces filing of 2022Annual Report on Form 10-K and 2022Universal Registration Document
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), today announced the filing of its Annual Report on Form 10-K for the year ended December 31, 2022, with the U.S. Securities and Exchange Commission (“SEC”) and the filing of its 2022 Universal Registration Document (“URD”) for the year ended December 31, 2022 with the French market authority, “Autorité des Marchés Financiers” (“AMF”).
These documents can be accessed on the Investors section of the Company's website at www.dbv-technologies.com. In addition, the URD is available on the AMF’s website at www.amf-france.org and the Form 10-K is available on the SEC’s website at www.sec.gov.
Printed copies of both documents are available, free of charge, at the Company’s headquarters and registered office located at 177-181 avenue Pierre Brossolette 92120 Montrouge, France.
About DBV Technologies
DBV Technologies is developing Viaskin™, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT™, DBV’s method of delivering biologically active compounds to the immune system through intact skin. With this new class of non-invasive product candidates, the Company is dedicated to safely transforming the care of food allergic patients. DBV’s food allergies programs include ongoing clinical trials of Viaskin Peanut. DBV Technologies has global headquarters in Montrouge, France, and North American operations in Summit, NJ. The Company’s ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and the Company’s ADSs (each representing one-half of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Transactions in connection with share buy-back program27.3.2023 15:00:41 CEST | Press release
Company Announcement COPENHAGEN, Denmark; March 27, 2023 –Genmab A/S (Nasdaq: GMAB). On February 22, 2023, Genmab announced the initiation of a share buy-back program to honor our commitments under our Restricted Stock Units program. The share buy-back program is expected to be completed no later than March 31, 2023, and comprises up to 220,000 shares. The following transactions were executed under the program from March 20, 2023, to March 24, 2023: No. of sharesAverage price (DKK)Total value (DKK)Accumulated through last announcement167,000427,631,620March 20, 20236,0002,504.2415,025,440March 21, 20235,000 2,541.7712,708,850March 22,20235,0002,541.4412,707,200March 23, 20237,0002,529.9917,709,930March 24, 20237,0002,564.9117,954,370Total30,00076,105,790Accumulated under the program197,000503,737,410 Details of each transaction are included as an appendix to this announcement. Following these transactions, Genmab holds 740,416 shares as treasury shares, corresponding to 1.12% of the to
Philips Virtual Care Management offers a comprehensive approach to telehealth for patients, providers and payers27.3.2023 15:00:00 CEST | Press release
March 27, 2023 New solution demonstrates proven results in improving patient engagement, health outcomes, and lowering cost of care while enabling workflow efficiencies Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the debut of Philips Virtual Care Management, a comprehensive portfolio of flexible solutions and services to help health systems, providers, payers and employer groups more meaningfully motivate and deeply connect with patients from virtually anywhere. Philips Virtual Care Management can help reduce pressure on hospital staff by decreasing emergency department visits, as well as reducing the cost of care through better management of chronic disease . Every year, chronic condition management represents 90% of healthcare expenditures in the USA . Philips Virtual Care Management’s condition-specific protocols now include diabetes, hypertension, heart disease, chronic kidney disease, chronic obst
Changes to the Yara Group Executive Board27.3.2023 15:00:00 CEST | Press release
Oslo, 27 March 2023: Pål Hestad, EVP Global Plants & Operational Excellence, has asked to step down from his current position for personal reasons, and will take on a different role in Yara. “Pål has safely led the Global Plants & Operational Excellence organization through an extraordinary period dominated by a pandemic and war which resulted in a demanding situation for a global operation like ours. Pål has now asked to step down and will continue to work for Yara in a different role. I would like to thank him for his contribution to the Group Executive Board over the past close to three years,” says Svein Tore Holsether, President & CEO. Pål will continue in the role until his replacement has been found. Contact Maria Gabrielsen, Investor Relations Mobile phone: +47 92090093 Email: email@example.com Tonje Næss, Media Relations Mobile phone: +47 40844647 Email: firstname.lastname@example.org About Yara Yara grows knowledge to responsibly feed the world and protect the planet. Supporting
Innovative Producer, Filmmaker and Author Mick Ebeling to Join Duck Creek’s Formation ’23 as Keynote Speaker27.3.2023 14:30:00 CEST | Press release
Ebeling will discuss pushing the bar and making the inconceivable, the unbelievable and the impossible, not impossible Boston, March 27, 2023 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, welcomes Mick Ebeling as its Formation ’23 keynote speaker. Formation, Duck Creek’s annual user conference, attracts the world’s leading insurance industry and technology minds and takes place in Orlando, FL, May 8-10, 2023. Ebeling is the founder and CEO of Not Impossible, a critically acclaimed, award-winning social lab and production company that taps into the power of technology and story to change the world. Formation '23 will empower the P&C and general insurance community with the insights, technology, and inspiration to build better human experiences. As the industry comes together to collaborate and reimage the future of P&C technology, the conference’s theme, “building together,” is me
NGS Group AB: Kallelse till årsstämma i NGS Group AB (publ)27.3.2023 14:15:00 CEST | Pressemelding
Aktieägarna i NGS Group AB (publ), org. nr 556535-1128 ("Bolaget") kallas härmed till årsstämma torsdagen den 27 april 2023, kl. 15.00 i Bolagets lokaler på Kungsgatan 12 i Stockholm. Inregistrering till stämman påbörjas klockan 14:30. Rätt att delta på bolagsstämman Aktieägare som vill delta på bolagsstämman ska: dels vara införd i den av Euroclear Sweden AB förda aktieboken avseende förhållandena per avstämningsdagen onsdagen den 19 april 2023,dels anmäla sig för deltagande på bolagsstämman till Bolaget under adress NGS Group AB (publ), Thomas Plate, Kungsgatan 12, 111 35 Stockholm, per telefon 0768-949 239 eller via e-post till email@example.com. Anmälan ska vara Bolaget tillhanda senast fredagen den 21 april 2023. Vid anmälan ska uppges namn, person- eller organisationsnummer (eller motsvarande), e‑postadress eller telefonnummer dagtid, samt antal aktier och eventuella biträden. Förvaltarregistrerade aktier För att ha rätt att delta i stämman måste en aktieägare som låtit förvaltarr